Attempts to induce tumor cell death drove intense worldwide research, starting from conventional chemotherapy in the mid-20th century [2] to novel selective approaches, including targeting of TNF (tumor necrosis factor alpha) receptor superfamily members. Here, TNF is linked to neoplasm.